SII Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,335
Closed -$273K 622
2017
Q2
$273K Sell
3,335
-1,291
-28% -$105K 0.02% 484
2017
Q1
$389K Sell
4,626
-598
-11% -$47.9K 0.03% 399
2016
Q4
$383K Sell
5,224
-699
-12% -$52.1K 0.03% 378
2016
Q3
$476K Buy
5,923
+2,775
+88% +$222K 0.04% 320
2016
Q2
$247K Sell
3,148
-1,206
-28% -$90.8K 0.02% 485
2016
Q1
$310K Sell
4,354
-844
-16% -$63.9K 0.03% 419
2015
Q4
$434K Sell
5,198
-1,229
-19% -$102K 0.05% 274
2015
Q3
$535K Sell
6,427
-1,223
-16% -$103K 0.06% 276
2015
Q2
$637K Buy
7,650
+66
+0.9% +$5.03K 0.08% 245
2015
Q1
$552K Buy
7,584
+285
+4% +$20.3K 0.07% 266
2014
Q4
$506K Sell
7,299
-65
-0.9% -$4.39K 0.07% 257
2014
Q3
$474K Buy
7,364
+352
+5% +$22.3K 0.06% 267
2014
Q2
$431K Buy
7,012
+511
+8% +$30.5K 0.06% 284
2014
Q1
$341K Hold
6,501
0.06% 283
2013
Q4
$329K Buy
+6,501
New +$326K 0.06% 299
2013
Q3
Sell
-6,190
Closed -$304K 350
2013
Q2
$304K Buy
+6,190
New +$337K 0.07% 281

Other funds holding LLY

SII Investments's LLY Position: Q3 2017 in Review

SII Investments sold out of Eli Lilly (LLY) in Q3 2017, closing a stake of 3,335 shares — an estimated $273K sold.

SII Investments first reported a position in LLY in Q2 2013 and held it in 16 quarters. The position peaked at $637K in Q2 2015. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • SII Investments reported no remaining Eli Lilly position as of Q3 2017 after selling out during the quarter.
  • SII Investments sold 3,335 Eli Lilly shares in Q3 2017, an estimated $273K.
  • SII Investments first reported a position in Eli Lilly in Q2 2013 and held it in 16 quarters.
  • SII Investments's Eli Lilly position peaked at $637K in Q2 2015.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on SII Investments's 13F filing for Q3 2017, filed 13 Nov 2017.